| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,860 | $40 | $175K |
| J9271 | Injection, pembrolizumab, 1 mg | 3,000 | $40 | $132K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,400 | $1 | $8.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 80 | $100 | $8.4K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 20 | $400 | $7.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 70 | $70 | $5.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 30 | $100 | $2.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 50 | $50 | $2.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 10 | $160 | $1.7K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 30 | $50 | $1.7K |